NCT02377778

Brief Summary

In this study the aim is to compare the effect of the type of anaesthetic drug used during oocyte retrieval on fertilization rates of oocytes retrieved after ovarian stimulation for in-vitro fertilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2009

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

February 25, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 4, 2015

Completed
Last Updated

March 4, 2015

Status Verified

February 1, 2015

Enrollment Period

4.2 years

First QC Date

February 25, 2015

Last Update Submit

March 3, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fertilization rate

    The number of oocytes fertilized divided by the number of oocytes in which fertilization was attempted per randomized patient

    First 24h after oocyte retrieval

Secondary Outcomes (4)

  • Number of MII oocytes

    12h after oocyte rertieval

  • Pregnancy rate

    14 days after embryo transfer

  • Implantation rate

    40 days after embryo traansfer

  • The concentration of propofol or thiopental in the follicular fluid of the dominant (larger) follicle aspirated at oocyte retrieval

    12 hours after oocyte retrieval

Study Arms (2)

Propofol

EXPERIMENTAL

In this arm patients will be receiving propofol for anaesthesia at doses 3-5mg depending on the time needed to complete oocyte retrieval

Drug: Propofol

Thiopental

ACTIVE COMPARATOR

In this arm patients will receive thiopental for anaesthesia at doses 7mg and a repeat dose of 2-3mg depending on the time needed to completed oocyte retrieval

Drug: Thiopental

Interventions

Propofol intravenous infusion for introduction and maintance of anaesthesia at doses 3-5mg depending on the total time needed for completion of oocyte retrieval

Propofol

Patients will receive thiopental in addition to fentanyl for introduction and maintanance of anaesthesia at doses 7mg. IF required patients will receive a repeat dose of 1-3mg of thiopental depending on the totla time needed to complete oocyte retrieval

Thiopental

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women undergoing oocyte retrieval for IVF under general anesthesia
  • age ≤45 years

You may not qualify if:

  • women with a known hypersensitivity to the active substance of the investigating drugs or any of their excipients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit for Human Reproduction, 1st Dept of OB/Gyn, Medical School, Aristotle UNiversity of Thessaloniki

Thessaloniki, Thessaloniki, 54603, Greece

Location

Related Publications (1)

  • Goutziomitrou E, Venetis CA, Kolibianakis EM, Bosdou JK, Parlapani A, Grimbizis G, Tarlatzis BC. Propofol versus thiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlled trial. Reprod Biomed Online. 2015 Dec;31(6):752-9. doi: 10.1016/j.rbmo.2015.08.013. Epub 2015 Sep 4.

MeSH Terms

Conditions

Infertility

Interventions

PropofolThiopental

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsThiobarbituratesBarbituratesPyrimidinonesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 25, 2015

First Posted

March 4, 2015

Study Start

January 1, 2009

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

March 4, 2015

Record last verified: 2015-02

Locations